CAS: 173253-42-4; 2-Amino-5-Bromo-6-Chloropyrazine

该化合物是一种卤化的双子苯并呋喃衍生物,在制药和农用化学研究方面具有重大效用,其独特的溴和氯替代成分可增强反应性,使其成为合成七环化合物的宝贵中间体.二号位置的地雷组为进一步实现功能化提供了一个多功能的场所,使目标分子得以开发.该复合物具有很高的纯度和稳定性,确保交叉反应和其他合成应用的可靠性能.其结构特征使其在药用化学中特别有助于生物活性剂的设计.建议在惰性条件下妥善处理和储存,以保持其完整性.

结构式图片

相似化合物

566205-01-4 960510-36-5 212779-21-0

上下游产品

CAS号33332-28-4 2-氨基-6-氯吡嗪

合成工艺路线路线简述

    2-氨基-6-氯吡嗪置于n-溴代丁二酰亚胺(Nbs)体系中,用 氯仿 用作溶剂,化学反应生成2-氨基-5-溴-6-氯吡嗪
    参考文献:N-Heterocyclyl Sulphonamide Derivatives And Their Use As Endothelin
    标题:N-Heterocyclyl Sulphonamide Derivatives And Their Use As Endothelin
    摘要:这项发明涉及药用价值的n-杂环磺胺衍生物,它们的药用盐,其制备方法,它们在人类或其他温血动物中拮抗内皮素一种或多种作用的用途,以及它们在治疗疾病或医疗状况的方法中的应用,其中内皮素的升高或异常水平起重要致病作用.

    专利信息


    专利号:US-2024239799-A1
    优先权日:2021-04-02
    标 题:(s)-1-(5-((pyridin-3-yl)thio)pyrazin-2-yl)-4'h,6'h-spiro[piperidine-4,5'-pyrrolo [1,2-b]pyrazol]-4'-amine derivatives and similar compounds as shp2 inhibitors for the treatment of e.g. cancer
    发明人:DI FABIO ROMANO; MONTALBETTI CHRISTIAN; PETROCCHI ALESSIA; GRILLO ALESSANDRO; RANDAZZO PIETRO; ROSSETTI ILARIA; CIAMMAICHELLA ALINA
    权利人:C N C C S S C A R L COLLEZIONE NAZ DEI COMPOSTI CHIMICI E CENTRO SCREENING; IRBM S P A
    摘要:The present invention relates to compounds of formula (I). The compounds of the formula (I) are e.g. (S)-1-(5-((pyridin-3-yl)thio) pyrazin-2-yl)-41H,6′H-spiro[piperidine-4,5′-pyrrolo[1,2-b]pyrazol]-41-amine derivatives and similar compounds. The present invention also relates to the compounds of formula (I) for use as Src homology phosphotyrosine phosphatase 2 (SHP2) inhibitors in methods of treatment of e.g. cancer, cardiovascular diseases, immunological disorders, autoimmune disorders, fibrosis, ocular disorders, systemic lupus erythematosus, diabetes, neutropenia, and combinations thereof. The present invention also relates to pharmaceutical compositions containing said compounds and to their methods of synthesis.

    专利号:US-2024409557-A1
    优先权日:2023-05-09
    标 题 :5,6-fused and 6,6-fused bicyclic alcohols and ethers and compositions for use as 15-prostaglandin dehydrogenase modulators
    发明人:GREENMAN KEVIN LLOYD; PICKRELL ALEXANDER J; LI KEXUE; AMEGADZIE ALBERT K; WANG HUI-LING; WEIRES NICHOLAS ANTHONY; ALLEN JOHN G; BOURBEAU MATTHEW P
    权利人:AMGEN INC
    摘要:The present disclosure provides novel 15-hydroxy-prostaglandin dehydrogenase inhibitors, pharmaceutical compositions comprising such compounds, and methods of using such compounds and compositions in treating 15-hydroxy-prostaglandin dehydrogenase-mediated disease. Also provided are methods of making such compounds and intermediates thereof. The compounds have a general Formula (A).Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (A).

    专利号:CN-117946013-B
    优先权日:2024-01-25
    标题:One-pot synthesis of 5,6-dihalogenated-3-aminopyrazine-2-carboxylic acid methyl ester

    专利号:US-7772246-B2
    优先权日:2007-08-01
    标题:Pyrazole compounds as RAF inhibitors
    发明人:CUI JINGRONG JEAN; DEAL JUDITH GAIL; GU DANLIN; GUO CHUANGXING; JOHNSON MARY CATHERINE; KANIA ROBERT STEVEN; KEPHART SUSAN ELIZABETH; LINTON MARIA ANGELICA; MCALPINE INDRAWAN JAMES; PAIRISH MASON ALAN; PALMER CYNTHIA LOUISE
    权利人:PFIZER
    摘要:The present invention is directed to compounds of Formula (I), n nand to pharmaceutically acceptable salts thereof, their synthesis, and their use as Raf inhibitors.

    专利号:CN-112724089-B
    优先权日:2021-01-05
    标题 :A kind of synthesis technique of 2-amino-3-bromo-6-chloropyrazine

    专利号:CN-112724089-A
    优先权日:2021-01-05
    标 题 :A kind of synthesis technique of 2-amino-3-bromo-6-chloropyrazine
    济南大宇化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinandayuchem.com
    企业联系电话:0531-87153728👤
    📞济南大宇化工有限公司 ⚠️参考联系方式
    联系人:徐经理
    电话:0531-87153728
    手机:13805401165
    传真:0531-87922099
    邮箱:xufeng192@126.com xufeng192@jinandayuchem.com
    通信地址: 济南市天桥区新材料交易产业园区西副楼
    邮编: 250022
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市天桥区新材料交易产业园区西副楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北巨龙堂医药化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jltpharm.com
    企业联系电话:027-82609301👤
    📞湖北巨龙堂医药化工有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:027-82609301
    手机:13971342059

    邮箱:798308538@qq.com
    通信地址: 武汉市江汉区常青路106号
    邮编: 430000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:武汉市江汉区常青路106号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/jm2007326
    摘要:Reader JC, Matthews TP, Klair S, Cheung KM, Scanlon J, Proisy N, Addison G, Ellard J, Piton N, Taylor S, Cherry M, Fisher M, Boxall K, Burns S, Walton MI, Westwood IM, Hayes A, Eve P, Valenti M, de Haven Brandon A, Box G, van Montfort RL, Williams DH, Aherne GW, Raynaud FI, Eccles SA, Garrett MD, Collins I. Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing. J Med Chem. 2011 Dec 22;54(24):8328–42.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知